secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001493152-24-004771
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera defers ~$4.3-4.5M payment to Feb 29; warrants exercised for 888K shares
--------------------------------------------------------------------------------

- Payment due Jan 31, 2024 deferred to Feb 29, 2024 under amended addendum to license and supply agreement.
- Institutional investor exercised pre-funded warrants for 888,000 shares; all such warrants now exercised.
- Total outstanding shares post-exercise: 2,572,628.
- Amended addendum details payment schedule: $2.791M due Dec 20, 2023; remainder and ~$2.9M PO due Feb 29.
- Failure to make timely payments under schedule constitutes immediate material breach with no cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315224004771/0001493152-24-004771-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315224004771/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004771

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer